Immunocore, one of UK biotech's brightest hopes ... and the first CAR-T therapies from Novartis and Kite Pharma, anticipated to gain approval in late 2017/ early 2018. The privately-held, Oxford ...

Hundreds of people in England with a rare form of cancer affecting the eye will soon be able to access a pioneering therapy based on T-cell receptor (TCR) technology, developed by Immunocore.

Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the ...

Companies that have grown profits and net profit margins over the past 12 months ...

After hours: February 13 at 5:40:21 PM EST Loading Chart for RYTM ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 22,961.89 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 98,782.96 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

IPC Indice de Precios Y Cotizaciones 52,926.31 108.56 0.21% ...

Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...